The largest database of trusted experimental protocols

Ultrafree mc

Manufactured by Merck Group
Sourced in United States, Germany

Ultrafree-MC is a laboratory filter unit designed for rapid and efficient separation of macromolecules, proteins, and other molecules from biological samples. It features a high-performance membrane that allows for efficient filtration and recovery of the desired components.

Automatically generated - may contain errors

63 protocols using ultrafree mc

1

Chiral Separation and Methanolic Extraction of Luminous Ostracods

Check if the same lab product or an alternative is used in the 5 most similar protocols
The methanolic solutions of chiral-separated (R)- and (S)-CypL were filtered through a centrifugal filter Ultrafree-MC (0.22 μm; Millipore, Billerica, MA, USA) and diluted 2 fold with methanol or mixed together in a 1:1 ratio. The methanolic extract of dried luminous ostracods was prepared as follows: ten dried luminous ostracods in a commercially available kit for observation of bioluminescence of sea-firefly (Hatenouruma, Tokyo) were homogenized in 200 μL of ice-cold methanol on ice and centrifuged at 14,000× g for 3 min at 4 °C followed by filtration through an Ultrafree-MC centrifugal filter (0.22 μm; Millipore). Ten microliter aliquots of these prepared solutions were subjected to chiral HPLC analysis. Chiral HPLC analysis was performed on a Waters ACQUITY UPLC H-Class system (Waters) equipped with a CHIRALCEL OZ-RH chiral column (ϕ4.6 × 150 mm, 5 μm; Daicel Chemical Industry), a multiwavelength detector (ACQUITY UPLC PDA eλ detector; Waters), and a fluorescence detector (ACQUITY FLR detector; Waters). The HPLC conditions were as follows: mobile phase, 30% (v/v) acetonitrile in a 100 mM solution of potassium hexafluorophosphate in H2O; flow rate, 0.8 mL min−1; fluorescence detection, excitation/emission, 430/570 nm.
+ Open protocol
+ Expand
2

Protein Extraction from Tissue Samples

Check if the same lab product or an alternative is used in the 5 most similar protocols
500 μl 10 mM sodium acetate buffer (pH 6.5) was added to 50 mg tissue in a 1.5 ml microfuge tube. Tissues were sonicated at 4 °C until completely dissolved. After sonication, tissues were spun at 14,000 g at 4°C for 10 min. Supernatant was collected and placed at 4 °C. This step was repeated three times and the three supernatants were combined. The cell free supernatants were spun at 15,000g for an additional 40 minutes. A 200 μl aliquot was taken for the determination of protein concentration using the Bradford method [44 (link)]. The remaining volume of each supernatant was filtered through a disposable membrane (0.22μm pore size) micropartition device (Millipore Ultrafree-MC) under centrifugation at 14,000g for 30 min at 4 °C to remove any compounds above 10,000 nominal molecular weight limit.
+ Open protocol
+ Expand
3

Subcellular Localization of INA in Blueberry Bark

Check if the same lab product or an alternative is used in the 5 most similar protocols
To localize INA in the subcellular fractions, bark tissues were excised from current-year stems of high-bush blueberry (cv. Weymouth). Two hundred grams of bark tissues were homogenized with mortar and pestle in 400 mL of 0.5 M mannitol, 20 mM glycylglycine–NaOH (pH 7.5), 5 mM MgCl2, 1 mM EDTA and 1 mM DTT. The homogenate was vacuum-filtrated through a 100-μm nylon mesh and two layers of filter paper. The filtrate was sequentially centrifuged at 200g for 10 min, 11 000 g for 10 min and 100 000 g for 1 h to obtain pellet fractions and soluble fraction (supernatant of 100 000 g). The soluble fraction was concentrated 50-fold using a centrifugal filter unit (10 000 MW cut off) (Ultrafree-MC, Millipore) followed by dialysis against 20 mM glycylglycine–NaOH (pH 7.5). The debris remaining on the filter papers was rinsed with 1000 mL of the homogenizing medium, followed by 1000 mL of 200 mM NaCl and finally with 1000 mL of Milli-Q water to give the cell wall fraction. For INT determination of each subcellular fraction, ∼20 mg of the cell wall fraction, 50 μL of the homogenate fraction (equivalent to ∼20 mg bark) or 1/200 volume fractions (equivalent to 1 g bark tissues) of the 200 g pellet, 11 000 g pellet, 100 000 g pellet and concentrated soluble fraction were dispensed into each tube (containing 0.5 mL water).
+ Open protocol
+ Expand
4

Quantification of Curcumin in Nanostructured Lipid Carriers

Check if the same lab product or an alternative is used in the 5 most similar protocols
At the end of the NLCs preparation process the volume of the whole formulation was measured. A total of 200 μL of NLC dispersion was withdrawn, transferred into a 10 mL flask and brought to volume with methanol to solubilize all components. Samples were analyzed by HPLC to quantify the total CUR (free and encapsulated) and detect any degradation products [25 (link)].
The free CUR, non-entrapped in nanoparticles, was investigated by two methods:

Dialysis assay: Dialysis tube (molecular weight cut off, MWCO, 12–14,000 Da, Visking Dialysis Membrane, Medicell Membranes Ltd., London, UK) was pre-activated and filled by 2 mL of CUR-NLC dispersion and submerged in 350 mL of distilled water, keeping at room temperature and under magnetic stir. After 24 h both the dispersion inside the tube and the external water were analyzed by HPLC.

Ultrafiltration assay: Aliquots of 0.45 mL of fresh samples were centrifuged (Microfuge 22R, Beckman coulter™ Brea, CA, USA) in two Ultrafree-MC (Millipore, Burlington, MA, USA) devices, with membrane cut-off of 10,000 NMWL and 30,000 NMWL, at 8000 rpm and 4 °C for 30 min [26 (link)]. In the end, the liquid ultrafiltrate was analyzed by HPLC.

+ Open protocol
+ Expand
5

Quantifying RSV Encapsulation in Lipid Nanoparticles

Check if the same lab product or an alternative is used in the 5 most similar protocols
The amount of RSV encapsulated into the LNPs was indirectly evaluated, as previously reported [41 (link)]. In brief, 1 mL of fresh LNP dispersion was diluted 10-fold with citrate buffer pH 5.5. Then, 0.5 mL of the obtained dispersion was placed into the upper chamber of a centrifuge filter tube equipped with an inert porous membrane (Ultrafree-MC, Millipore, Burlington, MA, USA, cut off 30,000 Da) and centrifuged at 4000 rpm for 20 min at room temperature. Subsequently, the liquor collected from the bottom chamber was subjected to HPLC-DAD analysis, as described below. This way, the free RSV quota (RSVout) was determined and the Drug Loading% (DL%) and Loading Efficacy% (LE%) values were indirectly calculated knowing the total amount of RSV in the dispersion (see above: DR%) as follows: DL%=RSVtotRSVout (mg)MIXF (mg)×100
LE%=RSVtotRSVout (mg)RSVtot×100
The analyses were performed in triplicate on each prepared batch of LNPs (n = 9), and results are reported as means ± SE.
+ Open protocol
+ Expand
6

Generation of sVEGFR-3 Expression Vector

Check if the same lab product or an alternative is used in the 5 most similar protocols
The sVegfr3 (nucleotides 91‐2413 from murine Flt4 NM_008029) sequence and the interleukin‐2 signal sequence for secretion (pBLAST2‐mFlt4 vector) were inserted into the pUNO1 expression vector (InvivoGen Inc.). The plasmid vector is regulated by the elongation factor‐1α/human T cell leukemia virus type 1 long terminal repeat hybrid promoter and includes blaR (blasticidin resistance gene). To generate the empty control vector, the sVegfr3 gene was deleted from the pBLAST2‐mFlt4 vector by digestion with AgeI/NheI. These vectors are referred to as psVEGFR‐3 and pVec (control), respectively, in this study. The vectors were isolated from Escherichia coli (DH5α strain) and purified by a modified alkaline lysis procedure using an endotoxin‐free Plasmid Maxi Kit (Qiagen, GmbH, Hilden, Germany) and further purified using centrifugal filters (Ultrafree‐MC, Millipore).
+ Open protocol
+ Expand
7

Oligomerization of Tau Protein

Check if the same lab product or an alternative is used in the 5 most similar protocols
Oligomerization of tau was performed as described (Ward et al. 2013 (link)). Briefly, the 2N4R isoform of human recombinant tau (rPeptide) was incubated at 4 µM with 75 µM of arachidonic acid in aggregation buffer (10 mM HEPES, pH 7.6, 100 mM NaCl, 0.1 mM EGTA, 5 mM DTT) for 6 h at room temperature with no agitation. To stop the reaction, the buffer was exchanged to PBS via 3 rounds of buffer exchange in a 10 kDa MWCO centrifugal filter (Millipore Ultrafree-MC). The sample was stored at −80 °C until analysis. Successful oligomerization was confirmed by Western immunoblotting (Supp. Fig. 1). For this, samples were diluted in Laemmli sample buffer without addition of a reducing agent or sample boiling. 10 ng of tau was loaded per well of a 4–20% Tris-Glycine SDS-polyacrylamide gel (Novex, ThermoFisher Scientific). After transfer, tau was detected using the DA31 total tau antibody (Acker et al. 2013 (link)) diluted to 1.5 µg/mL.
+ Open protocol
+ Expand
8

Quantitative Amino Acid Analysis by GC-MS

Check if the same lab product or an alternative is used in the 5 most similar protocols
Cells (0.5 mg CDW) were harvested in the mid-exponential growth phase by centrifugation (3 min, 16,000× g, 4°C, Biofuge Fresco, Heraeus, Hanau, Germany), washed twice with deionized water, and incubated with 30 µL 6 M HCl for 24 h at 100°C. The obtained hydrolysate was filtered (0.2 µm, Ultrafree MC, Millipore, Bedford, MA, USA) and then lyophilized. The proteinogenic amino acids in the lyophilisate were dissolved in 50 µL N, N-dimethylformamide containing 1% (v/v) pyridine and then derivatized at 80°C for 30 min with 50 µL N-methyl-t-butyldimethylsilyl-trifluoroacetamide (Macherey-Nagel, Düren, Germany). Mass isotopomer distributions of selected ion clusters of the analytes were then quantified using gas chromatography-mass spectrometry (GC-MS) (HP6890, M 5973, Agilent Technologies, Waldbronn, Germany) as described earlier [23] (link). All samples were first measured in scan mode to exclude isobaric overlay, and were analyzed in triplicate by selective ion monitoring to determine relative fractions of the mass isotopomers of interest [15] (link).
+ Open protocol
+ Expand
9

Size-Exclusion Chromatography of Protein Fractions

Check if the same lab product or an alternative is used in the 5 most similar protocols
EPP and UPP fractions were filtered through 0.45 μm filters (Ultrafree-MC, centrifugal filters, PVDF, Millipore Corp., Billerica, MA) by centrifugation at 16,900 g for 10 min (Eppendorf 5418). SEC was carried out using a Hewlett Packard Series II 1090 liquid chromatograph (Santa Clara, CA) fitted with a BioSep-SEC-s4000 column (7.8 × 300 mm, 5 μ particle dia, 500 Å pore size, Phenomenex, Torrance, CA) and a diode array detector set to monitor 210 nm. Data were acquired with a PC work station (Chem Station for Liquid Chromatography 3D System, Agilent Technologies, Santa Clara, CA). EPP and UPP (100 μL) were injected manually and proteins eluted at 0.5 ml/min with 50% acetonitrile/water/0.05% TFA. Three fractions were collected for each sample corresponding to peak 1: 9.6 to 14.3 min, ~2.4 ml; peak 2: 14.3 to 18 min, ~1.9 ml; peak 3: 18-20.5 min, ~1.3 ml. Fractions from 5 injections were pooled, stored at -20°C overnight and then vacuum dried (Speed Vac SC110, Savant Instruments, Farmingdale, NY). The protein amount in each fraction was determined by the method of Lowry
[28 (link)] as modified by Hurkman and Tanaka
[29 (link)].
+ Open protocol
+ Expand
10

Gadolinium Complex Albumin Binding

Check if the same lab product or an alternative is used in the 5 most similar protocols
Measurements were performed on a series of solutions ranging between 15-400 µM Gd complex in either 4.5% wt/v (HSA) or human blood plasma. A volume of 500 µL of each solution was placed within a Millipore Ultra Free MC 30 kDa cutoff filtration vessel and 20 µL of the solution was forced through the filter by centrifugation. Gd content in each unfiltered solution and filtrate were quantified by ICP-MS. The percentage of each complex bound to albumin was determined from the difference in Gd concentrations between unfiltered solution and filtrate.
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!